Turku, Finland

Aire Marja Laine

This inventor holds 1 USPTO granted patent. Top assignee: Risto Arvo Sakari Lammintausta. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aire Marja Laine. Retrieved from https://idiyas.com/inventor/aire-marja-laine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aire Marja Laine: Innovator in Selective Aromatase Inhibiting Compounds

Introduction

Aire Marja Laine is a notable inventor based in Turku, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective aromatase inhibiting compounds. His work is crucial in addressing estrogen-dependent diseases, such as breast cancer and benign prostatic hyperplasia (BPH).

Latest Patents

Aire Marja Laine holds a patent for "Selective aromatase inhibiting compounds." This patent describes new compounds of formula (I) that exhibit selective aromatase inhibiting properties compared to their desmolase inhibiting properties. The compounds are valuable in the treatment of estrogen-dependent diseases, showcasing their potential in medical applications.

Career Highlights

Aire Marja Laine has been associated with the company Risto Arvo Sakari Lammintausta. His innovative work has led to advancements in the pharmaceutical industry, particularly in the development of compounds that can effectively target specific health issues.

Collaborations

Aire has collaborated with notable coworkers, including Arto J Karjalainen and Marja-Liisa Sodervall. Their combined expertise has contributed to the success of their projects and the advancement of their research.

Conclusion

Aire Marja Laine's contributions to the field of selective aromatase inhibiting compounds highlight his role as an important inventor in the pharmaceutical industry. His work continues to pave the way for innovative treatments for estrogen-dependent diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…